SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 85 filers reported holding SESEN BIO INC in Q1 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,252 | -76.0% | 10,250 | -83.0% | 0.00% | – |
Q3 2022 | $26,000 | +2500.0% | 60,247 | +7932.9% | 0.00% | – |
Q2 2022 | $1,000 | -97.1% | 750 | -98.7% | 0.00% | – |
Q1 2022 | $34,000 | -55.3% | 56,672 | -39.5% | 0.00% | – |
Q4 2021 | $76,000 | +7500.0% | 93,647 | +5251.3% | 0.00% | – |
Q3 2021 | $1,000 | -97.5% | 1,750 | -79.9% | 0.00% | – |
Q2 2021 | $40,000 | +471.4% | 8,689 | +216.0% | 0.00% | – |
Q1 2021 | $7,000 | +250.0% | 2,750 | +85.8% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 1,480 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | -91.3% | 1,480 | -95.4% | 0.00% | – |
Q2 2020 | $23,000 | +53.3% | 31,900 | +17.1% | 0.00% | – |
Q1 2020 | $15,000 | +650.0% | 27,235 | +1740.2% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 1,480 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 1,480 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -84.6% | 1,480 | -88.1% | 0.00% | – |
Q1 2019 | $13,000 | +550.0% | 12,403 | +738.0% | 0.00% | – |
Q4 2018 | $2,000 | -77.8% | 1,480 | -66.3% | 0.00% | – |
Q3 2018 | $9,000 | – | 4,394 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP, LLC | 4,091,591 | $18,903,000 | 100.00% |
Schonfeld Strategic Advisors LLC | 3,828,200 | $17,687,000 | 0.19% |
Virtus ETF Advisers LLC | 52,632 | $243,000 | 0.10% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 711,500 | $3,287,000 | 0.06% |
WealthTrust Axiom LLC | 39,750 | $183,000 | 0.06% |
CAXTON ASSOCIATES LP | 84,801 | $392,000 | 0.04% |
Stratos Wealth Partners, LTD. | 352,500 | $1,629,000 | 0.04% |
ClariVest Asset Management LLC | 260,500 | $1,203,000 | 0.04% |
TWO SIGMA ADVISERS, LP | 2,766,318 | $12,780,000 | 0.03% |
TWO SIGMA INVESTMENTS, LP | 3,150,574 | $14,556,000 | 0.03% |